Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. - Langlois, Julie; Lange, Simona; Ebeling, Martin; Macnair, Will; Schmucki, Roland; Li, Cenxiao; DeGeer, Jonathan; Sudharshan, Tania J. J.; Yong, V. Wee; Shen, Yun-An; Harp, Christopher; Collin, Ludovic; et al. (Journal of Neuroinflammation, 2024)